Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra

NCT00648999 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT00648999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00648999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2003
Completion date
December 31, 2006
Enrollment
207 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus